header
Local cover image
Local cover image
Image from OpenLibrary

Stem cell therapy in multiple sclerosis / Mustafa Ibrahim Abdelaziz Emara ; Supervised Manal Fahmy , Nermin Adel Kishk

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Mustafa Ibrahim Abdelaziz Emara , 2014Description: 184 P. : facsimiles ; 25cmOther title:
  • استخدام الخلايا الجذعية لعلاج مرض التصلب المتناثر للجهاز العصبى [Added title page title]
Subject(s): Online resources: Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Neuropsychiatry Summary: HSCT and MSCT offer hope for a new effective treatment for MS. Recent trials of low intensity HSCT indicate that as researchers improve the conditioning protocol, they can significantlyreduce the adverse side effects without decreasing efficacy. Similarly, a recent clinical trial evaluating MSCT concluded it was a feasible and safe treatment method for MS patients. Given MSCT{u2019}s positive potential on neural restoration and immunomodulation demonstrated in animal models, MSCT offers a low risk/high reward treatment option for MS patients. Additionally, HSCT and MSCT could work synergistically to further decrease adverse side effects and increase patient outcomes
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.21.M.Sc.2014.Mu.S (Browse shelf(Opens below)) Not for loan 01010110064350000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.21.M.Sc.2014.Mu.S (Browse shelf(Opens below)) 64350.CD Not for loan 01020110064350000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Neuropsychiatry

HSCT and MSCT offer hope for a new effective treatment for MS. Recent trials of low intensity HSCT indicate that as researchers improve the conditioning protocol, they can significantlyreduce the adverse side effects without decreasing efficacy. Similarly, a recent clinical trial evaluating MSCT concluded it was a feasible and safe treatment method for MS patients. Given MSCT{u2019}s positive potential on neural restoration and immunomodulation demonstrated in animal models, MSCT offers a low risk/high reward treatment option for MS patients. Additionally, HSCT and MSCT could work synergistically to further decrease adverse side effects and increase patient outcomes

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer

Local cover image
Share
Under the supervision of New Central Library Manager

Implemented and Customized by: Eng.M.Mohamady
Contact:   info@cl.cu.edu.eg

© All rights reserved  New Central Library